ResearcherHarbin Medical UniversityActive in the last 2 years

Wenjing Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5638-5892; OpenAlex author ID A5102918681. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Regulation of the Hippo/YAP signaling pathway in pancreatic cancer by the deubiquitinase POH1 Last author DOI 10.21203/rs.3.rs-6633989/v1 ↗
The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in Pancreatic Cancer Cells Co-author DOI 10.21203/rs.3.rs-1374979/v1 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaodong Tan · 1 shared paper, 2025 · strength 0.22
- Paper Regulation of the Hippo/YAP signaling pathway in pancreatic cancer by the deubiquitinase POH1 DOI 10.21203/rs.3.rs-6633989/v1 ↗
Jian Zhu · 1 shared paper, 2025 · strength 0.22
- Paper Regulation of the Hippo/YAP signaling pathway in pancreatic cancer by the deubiquitinase POH1 DOI 10.21203/rs.3.rs-6633989/v1 ↗
Zhihao Liu · 1 shared paper, 2025 · strength 0.22
- Paper Regulation of the Hippo/YAP signaling pathway in pancreatic cancer by the deubiquitinase POH1 DOI 10.21203/rs.3.rs-6633989/v1 ↗
Jianjun Gao · 1 shared paper, 2022 · strength 0.17
- Paper The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in P… DOI 10.21203/rs.3.rs-1374979/v1 ↗
Dongsheng Wang · 1 shared paper, 2022 · strength 0.17
- Paper The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in P… DOI 10.21203/rs.3.rs-1374979/v1 ↗
Hao Wang · 1 shared paper, 2022 · strength 0.17
- Paper The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in P… DOI 10.21203/rs.3.rs-1374979/v1 ↗
Xiangyu Zhong · 1 shared paper, 2022 · strength 0.17
- Paper The Second-Generation Proteasome Inhibitor Ixazomib Enhances the Anticancer Effects of Gemcitabine or Fluorouracil in P… DOI 10.21203/rs.3.rs-1374979/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.